U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula 2C7H5O3.2C5H14NO.Mg.O4S.4H2O
Molecular Weight 674.996
Optical Activity NONE
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SALCOLEX

SMILES

O.O.O.O.[Mg++].[O-]S([O-])(=O)=O.C[N+](C)(C)CCO.C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC2=CC=CC=C2C([O-])=O

InChI

InChIKey=GQVWFGYYMWLERN-UHFFFAOYSA-J
InChI=1S/2C7H6O3.2C5H14NO.Mg.H2O4S.4H2O/c2*8-6-4-2-1-3-5(6)7(9)10;2*1-6(2,3)4-5-7;;1-5(2,3)4;;;;/h2*1-4,8H,(H,9,10);2*7H,4-5H2,1-3H3;;(H2,1,2,3,4);4*1H2/q;;2*+1;+2;;;;;/p-4

HIDE SMILES / InChI

Description

Salcolex is a salicylic acid derivative. Analgesic, anti-inflammatory, antipyretic. It is Choline salicylate used in combination with MgSO4.

Approval Year

Unknown
149,124

Targets

Primary TargetPharmacologyConditionPotency
prostaglandin biosynthetic process
23
Inhibitor
8,504

Conditions

ConditionModalityTargetsHighest PhaseProduct
Pain
619
 Palliative
Approved
8,583
Audax

Sample Use Guides

In Vivo Use Guide
Oral Pain and fever Adult: 435-870 mg every 4 hr when required. Oral Rheumatic disorders Adult: 4.8-7.2 g daily in divided doses. Buccal Mouth lesions Adult: Apply 8.7% gel on affected area.
Route of Administration: Other
In Vitro Use Guide
Unknown
PARENT (SALT/SOLVATE)
Structure of CHOLINE
PARENT (SALT/SOLVATE)
Structure of Salicylic acid
SUBSTANCE RECORD
Structure of SALCOLEX
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966